Azathioprine with Allopurinol Is a Promising First‑Line Therapy for Infammatory Bowel Diseases

Prevalence of polymorphisms in thiopurine metabolism and association with adverse outcomes

Mimics of Inflammatory Bowel Disease in Clinical Practice

Inflammatory bowel disease in Bahrain: single-center experience

Epidemiology of Inflammatory Bowel Diseases in Nepal

Antibiotics for induction and maintenance of remission in UC: systematic review and meta-analysis

Optimization of infliximab therapy in inflammatory bowel disease using a dashboard approach

Combination of sarcopenia and high visceral fat predict poor outcomes in patients with Crohn's

Noninvasive Monitoring After Azathioprine Withdrawal in Patients with Inflammatory Bowel Disease

Impact of diagnostic delay to the clinical presentation and associated factors in pediatric IBD

Vedolizumab Tissue Concentration Correlates to Mucosal Inflammation and Objective Treatment

Real-World Effectiveness and Safety of Tofacitinib in Crohn's Disease and IBD-U